The burgeoning field of obesity management has witnessed remarkable advancements with the emergence of dual GLP-3 receptor agonists, notably Retatrutide and Trizepatide. These groundbreaking therapies represent a https://andrewqcxd327263.blogscribble.com/38953235/glp-3-receptor-agonists-retatrutide-trizepatide